High incidence of reassortant G9P[4] rotavirus strain in Bangladesh: Fully heterotypic from vaccine strains

Journal of Clinical Virology

Volumn 58, Issue 4, 2013, Pages 755-756

  Afrad, Mokibul Hassan ^a   Rahman, Mohammed Ziaur ^a   Matthijnssens, Jelle ^b   Das, Sumon Kumar ^a   Faruque, ASG ^a   Azim, Tasnim ^a   Rahman, Mustafizur ^a  

^a INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VP6; ROTAVIRUS VACCINE;

BANGLADESH; DIARRHEA; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG EFFICACY; ENZYME IMMUNOASSAY; FECES ANALYSIS; GASTROENTERITIS; GENETIC REASSORTMENT; GENOTYPE; HUMAN; LETTER; LOWEST INCOME GROUP; MIXED INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROTAVIRUS; VIRUS STRAIN;

ADULT; AGED; AGED, 80 AND OVER; BANGLADESH; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; GENOTYPE; HUMANS; INCIDENCE; INFANT; MIDDLE AGED; MULTIPLEX POLYMERASE CHAIN REACTION; REASSORTANT VIRUSES; ROTAVIRUS; ROTAVIRUS INFECTIONS; ROTAVIRUS VACCINES; YOUNG ADULT;

EID: 84888856290     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.09.024     Document Type: Letter

References (8)

1. Jiang V., Jiang B., Tate J., Parashar U.D., Patel M.M. Performance of rotavirus vaccines in developed and developing countries. Human Vaccines 2010, 6:532-542.
2. Rahman M., Alamgir A.S., Saiada F., Hassan Z., Faruque A.S., Cravioto A., et al. Co-circulation of G1 G2 and G9 rotaviruses in hospitalized patients in Bangladesh during 2006-2009. Human Vaccines 2011, 7:929-933.
3. Gouvea V., Glass R.I., Woods P., Taniguchi K., Clark H.F., Forrester B., et al. Polymerase chain reaction amplification and typing of rotavirus nucleic acid from stool specimens. Journal of Clinical Microbiology 1990, 28:276-282.
4. Matthijnssens J., Heylen E., Zeller M., Rahman M., Lemey P., Van Ranst M. Phylodynamic analyses of rotavirus genotypes G9 and G12 underscore their potential for swift global spread. Molecular Biology and Evolution 2010, 27:2431-2436.
5. Linhares A.C., Stupka J.A., Ciapponi A., Bardach A.E., Glujovsky D., Aruj P.K., et al. Burden and typing of rotavirus group A in Latin America and the Caribbean: systematic review and meta-analysis. Reviews in Medical Virology 2011, (March). [Epub ahead of print]. 10.1002/rmv.682.
6. Quaye O., McDonald S., Esona M.D., Lyde F.C., Mijatovic-Rustempasic S., Roy S., et al. Rotavirus G9P[4] in 3 Countries in Latin America, 2009-2010. Emerging Infectious Diseases 2013, 19.
7. Yen C., Figueroa J.R., Uribe E.S., Carmen-Hernandez L.D., Tate J.E., Parashar U.D., et al. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. The Journal of Infectious Diseases 2011, 204:783-786.
8. Zaman K., Dang D.A., Victor J.C., Shin S., Yunus M., Dallas M.J., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010, 376:615-623.